Acumen Pharmaceuticals, Inc.
ABOS· Nasdaq
Acumen Pharmaceuticals, Inc.
- Last sale
- Oct 2, 2026 · -1.45%
- Market cap
- $147.53M
- 72.32M shares
- Filings
- 358
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $104,885,000 | reported | |
| FY 2024 | 2024-12-31 | $93,798,000 | reported | |
| FY 2023 | 2023-12-31 | $42,318,000 | reported | |
| FY 2022 | 2022-12-31 | $32,361,000 | reported | |
| FY 2021 | 2021-12-31 | $12,305,000 | reported | |
| FY 2020 | 2020-12-31 | $7,997,000 | reported |
Acumen Pharmaceuticals, Inc. · CIK 1576885 · Engraved from SEC EDGAR
